Amarin Pulls Insurer Into Hikma/Vascepa Induced Infringement Suit
Originator Sued Hikma For Induced Infringement Late Last Year
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.
